[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,578,176
  • Shares Outstanding, K 105,720
  • Annual Sales, $ 14,343 M
  • Annual Income, $ 4,505 M
  • EBIT $ 3,629 M
  • EBITDA $ 4,173 M
  • 60-Month Beta 0.30
  • Price/Sales 5.23
  • Price/Cash Flow 16.89
  • Price/Book 2.39

Options Overview Details

View History
  • Implied Volatility 36.28% (+1.07%)
  • Historical Volatility 30.85%
  • IV Percentile 40%
  • IV Rank 44.15%
  • IV High 49.01% on 10/10/25
  • IV Low 26.22% on 11/26/25
  • Expected Move (DTE 5) 25.48 (3.56%)
  • Put/Call Vol Ratio 1.14
  • Today's Volume 1,298
  • Volume Avg (30-Day) 1,911
  • Put/Call OI Ratio 1.02
  • Today's Open Interest 43,950
  • Open Int (30-Day) 39,492
  • Expected Range 689.41 to 740.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $8.40
  • Number of Estimates 7
  • High Estimate $11.13
  • Low Estimate $6.29
  • Prior Year $10.72
  • Growth Rate Est. (year over year) -21.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
668.84 +6.88%
on 04/29/26
772.45 -7.45%
on 04/09/26
-60.64 (-7.82%)
since 04/08/26
3-Month
668.84 +6.88%
on 04/29/26
815.00 -12.28%
on 02/17/26
-70.62 (-8.99%)
since 02/06/26
52-Week
476.49 +50.03%
on 06/05/25
821.11 -12.94%
on 01/09/26
+167.22 (+30.53%)
since 05/08/25

Most Recent Stories

More News
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years

Regeneron also earns spot on Dow Jones Best-in-Class North America Index for six consecutive years Recognition complements the company’s recent announcement that it will provide its new gene therapy...

REGN : 714.89 (+0.82%)
Biotech’s Next Wave May Already be in Motion

DENVER, May 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com and NeOnc Technology) - The biotech and pharma sector is entering one of its most pivotal periods in years, where insider conviction,...

NTHI : 5.45 (-16.02%)
NVO : 46.07 (+0.59%)
LLY : 948.45 (-2.72%)
REGN : 714.89 (+0.82%)
5 Must-Read Analyst Questions From Regeneron’s Q1 Earnings Call

5 Must-Read Analyst Questions From Regeneron’s Q1 Earnings Call

REGN : 714.89 (+0.82%)
Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying

Despite Intellia's severe stock drop from its 2021 peak, Cathie Wood is buying big.

ARKG : 30.48 (+0.33%)
REGN : 714.89 (+0.82%)
NTLA : 14.09 (+2.77%)
ARKK : 79.12 (+1.53%)
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial

Dupixent showed significant and clinically meaningful improvements in both esophageal distensibility as well as disease-related structural changes and inflammation in the esophagus in adult patients with...

REGN : 714.89 (+0.82%)
1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds

1 Cash-Producing Stock Worth Investigating and 2 Facing Headwinds

QRHC : 1.1500 (+6.48%)
REGN : 714.89 (+0.82%)
UNH : 379.98 (+2.77%)
REGN Q1 Deep Dive: Product Expansion Drives Growth, Margin Pressures Draw Scrutiny

REGN Q1 Deep Dive: Product Expansion Drives Growth, Margin Pressures Draw Scrutiny

REGN : 714.89 (+0.82%)
3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar

REGN : 714.89 (+0.82%)
CRL : 177.62 (-2.23%)
AHCO : 11.30 (-3.67%)
Why Regeneron (REGN) Shares Are Getting Obliterated Today

Why Regeneron (REGN) Shares Are Getting Obliterated Today

REGN : 714.89 (+0.82%)
Regeneron (NASDAQ:REGN) Reports Strong Q1 CY2026

Regeneron (NASDAQ:REGN) Reports Strong Q1 CY2026

REGN : 714.89 (+0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 728.76
2nd Resistance Point 723.38
1st Resistance Point 719.13
Last Price 714.89
1st Support Level 709.50
2nd Support Level 704.12
3rd Support Level 699.87

See More

52-Week High 821.11
Last Price 714.89
Fibonacci 61.8% 689.46
Fibonacci 50% 648.80
Fibonacci 38.2% 608.13
52-Week Low 476.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.